Jay M. Short Ph.D., Chief Executive Officer at BioAtla, Inc. (BCAB), sold 93,753 shares at $26.24 ($2.4M) on 2021-11-22, disclosed to the SEC on 2021-11-30.
Open-market sale of $2.4M BCAB by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.24 | 15,675 | $411K | 17.5% |
| 2 | $24.29 | 15,861 | $385K | 16.4% |
| 3 | $24.29 | 15,861 | $385K | 16.4% |
| 4 | $26.04 | 9,082 | $236K | 10.0% |
| 5 | $26.04 | 9,082 | $236K | 10.0% |
| 6 | $24.05 | 6,311 |
| $152K |
| 6.4% |
| 7 | $24.05 | 6,311 | $152K | 6.4% |
| 8 | $25.00 | 5,852 | $146K | 6.2% |
| 9 | $25.77 | 4,859 | $125K | 5.3% |
| 10 | $25.77 | 4,859 | $125K | 5.3% |
| Total | $25.12 avg | 93,753 | $2.4M | 100% |
| Filing → |
| BCAB | BUY | 2022-08-15 | $207K | — | Filing → |
| BCAB | BUY | 2022-06-23 | $397K | — | Filing → |
| BCAB | SELL | 2021-12-07 | $2.1M | — | Filing → |